Workflow
Oncolytic viral immunotherapies
icon
Search documents
Genelux (GNLX) - Prospectus
2023-06-28 00:07
As filed with the Securities and Exchange Commission on June 27, 2023 Registration No. 333- Genelux Corporation 2625 Townsgate Road, Suite 230 Westlake Village, California 91361 (805) 267-9889 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Genelux Corporation (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 77-0583529 Primary Standard In ...